Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis

被引:46
作者
Higuchi, Kazue [1 ]
Harada, Nobuyuki [1 ]
Fukazawa, Keiji [2 ]
Mori, Toru [1 ]
机构
[1] Japan Anti TB Assoc, Res Inst TB, Div Immunol, Tokyo 2048533, Japan
[2] Nakano Publ Hlth Ctr, Nakano Ku, Tokyo 1640001, Japan
关键词
active tuberculosis; ESAT-6; CFP-10; IFN-gamma response; LTBI;
D O I
10.1016/j.tube.2007.11.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have analyzed the relationship between the responses to the diagnostic method for Mycobacterium tuberculosis (Mtb) infection, QuantiFERON (R)-TB Gold (QFT-G), and the risk of developing active tuberculosis (TB). Contacts under 42 years old who were exposed to a patient with infectious pulmonary TB were tested using QFT-G during an investigation. Among 172 contacts, 111 (64.5%) were QFT-G positive. All subjects were evaluated for active TB by chest X-ray examination and, if needed, by CT scan at the time of the QFT-G test and 39 were diagnosed with active TB based on radiological abnormalities consistent with TB. Of these, 35 (89.7%) were QFT-G positive. Statistically the geometric mean of interferon-gamma (IFN-gamma) production levels of the active TB group was significantly larger than that of the latent TB infection group (p = 0.013). The results of the multivariate analysis clearly showed that a combined parameter of ESAT-6 and CFP-10 significantly contributes to disease risk for the infected subjects. Our results suggest that subjects with high levels of IFN-gamma production in response to either ESAT-6 and/or CFP-10 in the QFT-G test have a higher possibility of developing active TB than QFT-G positive subjects with tower levels of IFN-gamma. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:244 / 248
页数:5
相关论文
共 25 条
[1]  
Adetifa IMO, 2007, INT J TUBERC LUNG D, V11, P350
[2]   Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases [J].
Aiken, Alexander M. ;
Hill, Philip C. ;
Fox, Annette ;
McAdam, Keith P. W. J. ;
Jackson-Sillah, Dolly ;
Lugos, Moses D. ;
Donkor, Simon A. ;
Adegbola, Richard A. ;
Brookes, Roger H. .
BMC INFECTIOUS DISEASES, 2006, 6 (1)
[3]   The prognosis of latent tuberculosis: can disease be predicted [J].
Andersen, Peter ;
Doherty, T. Mark ;
Pai, Madhukar ;
Weldingh, Karin .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (05) :175-182
[4]   Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts [J].
Brock, L ;
Weldingh, K ;
Lillebaek, T ;
Follmann, F ;
Andersen, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (01) :65-69
[5]   Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy [J].
Carrara, S ;
Vincenti, D ;
Petrosillo, N ;
Amicosante, M ;
Girardi, E ;
Goletti, D .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :754-756
[6]  
Chan John, 1994, P389
[7]   PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE [J].
COMSTOCK, GW ;
LIVESAY, VT ;
WOOLPERT, SF .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1974, 99 (02) :131-138
[8]  
Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002
[9]  
Ferebee SH., 1969, Adv Tuberc Res, V17, P28
[10]   Screening for tuberculosis infection using whole-blood interferon-γ and mantoux testing among Japanese healthcare workers [J].
Harada, Nobuyuki ;
Nakajima, Yutsuki ;
Higuchi, Kazue ;
Sekiya, Yukie ;
Rothel, Jim ;
Mori, Toru .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (05) :442-448